Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer.

Maxwell-Armstrong, CA; Durrant, LG; Buckley, TJ; Scholefield, JH; Robins, RA; Fielding, K; Monson, JR; Guillou, P; Calvert, H; Carmichael, J; +1 more... Hardcastle, JD; (2001) Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. British journal of cancer, 84 (11). pp. 1443-1446. ISSN 0007-0920 DOI: https://doi.org/10.1054/bjoc.2001.1725

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1054/bjoc.2001.1725

Abstract

Share

Download

Filename: 84-6691725a.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar